
ESMO 2022 Conference Coverage
ESMO 2022 on the Results of the Randomized DICIPLE Phase 3 Trial: Nivo + Ipi 6-Month Treatment vs. Continuation in Advanced NSCLC
By
ESMO 2022 Conference Coverage
FEATURING
Gerard Zalcman
By
ESMO 2022 Conference Coverage
FEATURING
Gerard Zalcman
1,102 views
September 15, 2022
Comments 0
Login to view comments.
Click here to Login
Lung